CareLit · DOI-Nachweis · Aktuelle Neurologie
NT201 (Xeomin) in upper limb post-stroke spasticity: results of a double-blind, placebo-controlled, randomised, multi-centre trial
DOI 10.1055/s-0028-1086854
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Kanovsky, I Sassin, G Comes, S Grafe
ZeitschriftAktuelle Neurologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: Efficacy and safety of NT 201 in treatment of patients with upper limb post-stroke spasticity were investigated in a placebo-controlled, multi-centre trial. Background: NT 201 is a new formulation of botulinum neurotoxin type A which is free from complexing proteins. In contrast to other preparations of botulinum neurotoxin, NT 201 has not been associated with immunogenicity in animal models. Methods: Pat…
Zitieren
Zitierempfehlung
P Kanovsky, I Sassin, G Comes, S Grafe (2008) NT201 (Xeomin) in upper limb post-stroke spasticity: results of a double-blind, placebo-controlled, randomised, multi-centre trial. Aktuelle Neurologie (09). https://doi.org/10.1055/s-0028-1086854
Mit CareLit weiterarbeiten